EMERGE ARK GLOBAL DISRUPTIVE INNOVATION ETF

Ticker: EARK

Emerge goes live with Simon Barnett (Genomics Analyst, ARK Invest) on February 3rd at 3.00pm ET

Investment Objectives

EARK is an actively managed exchange-traded fund (ETF) that seeks to achieve long-term growth of capital by investing primarily, under normal circumstances, in the global equity securities of companies that are, or expected to be, focused on disruptive innovation, meaning the introduction of technologically enabled new products or services that could potentially change the way the world works.

Profile of an Innovator : Portfolio Manager

Catherine Wood founded ARK Investment Management in 2014. She spent the previous 12 years at AllianceBernstein as Chief Investment Officer of Global Thematic Strategies that had over US$5 billion in assets under management. Before AllianceBernstein, she worked for 18 years with Jennison Associates as Chief Economist, Equity Research Analyst, Portfolio Manager and Director. Catherine started her career in Los Angeles at the Capital Group as an Assistant Economist.

Why Invest?

Exposure to Innovation: Aims to achieve thematic multi-capitalization exposure to innovation across sectors. ARK believes the securities held in EARK present the best risk-reward opportunities from ARK’s innovation-based themes.

Growth Potential: Aims to capture long-term growth, with low correlation of relative returns to traditional growth strategies and negative correlation to value strategies.

Tool for Diversification: Active stock selection results in little overlap with traditional indices. EARK can be a complement to traditional value/growth strategies.

Grounded in Research: Combines top-down and bottom-up research in its portfolio management to identify innovative companies and convergence across markets.

Cost Effective: Provides a lower-cost alternative to mutual funds with true active management in an ETF that invests in rapidly moving themes.

Top 10 Holdings

As at December 31, 2020

Tesla Inc.10.57%
Roku Inc6.89%
CRISPR Therapeutics AG5.53%
Square Inc5.25%
Teladoc Health Inc4.36%
Invitae Corporation 4.13%
Zillow Group Inc3.09%
Pure Storage Inc 2.81%
Proto Labs Inc2.79%
Editas Medicine Inc2.69%
Click Here to Download EARK Full Holdings Report as of Dec. 31, 2020.
Fund Facts

EARK NAV (As at January 20th, 2021):
$27.05
EARK.U NAV (As at January 20th, 2021):
$21.42

CUSIP CAD Series: 291006104
CUSIP USD Series: 291006203
TICKER: EARK
INCEPTION DATE: 7.29.2019
EXCHANGE: NEO Stock Exchange
MANAGEMENT FEE: 0.80%
CURRENCY: CAD/USD
SUB-ADVISORS: ARK Investment Management LLC

Fund Characteristics

As at December 31, 2020

  • Americas 79.24%
  • Europe 10.06%
  • Asia 9.38%
  • Middle East 0.74%
Sector Allocation

As at December 31, 2020

  • Health Care 31.44%
  • Information Technology 20.68%
  • Consumer Discretionary 12.47%
  • Communication Services 23.16%
  • Financials 8.89%
  • Industrials 2.78%